Therapeutic Potential of Nrf2 Activators in Streptozotocin-Induced Diabetic Nephropathy
Diabetes2011Vol. 60(11), pp. 3055–3066
Citations Over TimeTop 1% of 2011 papers
Hongting Zheng, Samantha A. Whitman, Wei Wu, Georg T. Wondrak, Pak Kin Wong, Deyu Fang, Donna D. Zhang
Abstract
We provide experimental evidence indicating that dietary compounds targeting Nrf2 activation can be used therapeutically to improve metabolic disorder and relieve renal damage induced by diabetes.
Related Papers
- → Modification of Renal Tumorigenic Effect of Streptozotocin by Nicotinamide: Spontaneous Reversibility of Streptozotocin Diabetes(1976)37 cited
- → Age-Dependent Changes in the Sensitivity of the Rat to a Diabetogenic Agent (Streptozotocin)(1975)20 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → DETERMINING QUALITY REQUIREMENTS AT THE UNIVERSITIES TO IMPROVE THE QUALITY OF EDUCATION(2018)
- → ИСПОЛЬЗОВAНИЕ ПОТЕНЦИAЛA СОЦИAЛЬНЫХ ПAРТНЕРОВ В ПОДГОТОВКЕ БУДУЩИХ ПЕДAГОГОВ(2024)